SYR-472
SYR-472/CCT-101
Phase 3 small_molecule completed
Quick answer
SYR-472 for Type 2 Diabetes Mellitus is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Type 2 Diabetes Mellitus
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed